The Cooper Companies, Inc. (COO) Operating Margin: 11.77%
Is The Cooper Companies, Inc.’s operating margin high or low?
The Cooper Companies, Inc.'s operating margin of 11.77% is 26% below its 5-year average of 15.86%, near the low end of its 5-year range (11.77%–18.12%).
As of Sunday, June 14, 2026. 32.38% below its 12-month average of 17.41%.
COO Operating Margin Chart
COO Average Operating Margin Chart
COO Current vs Average Operating Margin Chart
COO Operating Margin Metrics
OPERATING MARGIN
11.77%
OPERATING MARGIN AVG TTM
17.41%
OPERATING MARGIN AVG 3Y
16.25%
OPERATING MARGIN AVG 5Y
15.86%
OPERATING MARGIN AVG 10Y
16.49%
OPERATING MARGIN AVG 15Y
16.97%
OPERATING MARGIN AVG 20Y
15.82%
CURRENT VS TTM AVG
-32.38%
CURRENT VS 3Y AVG
-27.56%
CURRENT VS 5Y AVG
-25.76%
CURRENT VS 10Y AVG
-28.61%
CURRENT VS 15Y AVG
-30.66%
CURRENT VS 20Y AVG
-25.59%
COO Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 11.77% | 17.41% | 16.25% | 15.86% |
| Solventum Corporation (SOLV) | $13.66B | 25.54% | 19.38% | 20.05% | 20.47% |
| Align Technology, Inc. (ALGN) | $12.52B | 14.44% | 15.23% | 16.08% | 17.45% |
| Baxter International Inc. (BAX) | $10.77B | -2.65% | -1.31% | -6.02% | 0.15% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -2.02% | -7.24% | -2.92% | -1.15% |
| Hologic, Inc. (HOLX) | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 11.77% | 9.13% | 12.39% | 13.51% |
| Tempus AI, Inc. (TEM) | $8.35B | -18.13% | -59.22% | -59.52% | -72.58% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 9.25% | 10.48% | 12.70% | 14.08% |
| Moderna, Inc. (MRNA) | $19.80B | -153.35% | -140.72% | -73.36% | -52.24% |
Operating Efficiency
Gross Margin
64.4%
Operating Margin
11.8%
The Cooper Companies, Inc. Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Operating Margin FAQ
- What is the operating margin for The Cooper Companies, Inc. (COO)?
- The operating margin for COO stock is 11.77%.
- Is The Cooper Companies, Inc.'s operating margin high or low?
- The Cooper Companies, Inc.'s operating margin of 11.77% is 26% below its 5-year average of 15.86%, near the low end of its 5-year range (11.77%–18.12%).
- What is the TTM average operating margin for The Cooper Companies, Inc. (COO)?
- The TTM average operating margin for COO stock is 17.41%.
- What is the 3Y average operating margin for The Cooper Companies, Inc. (COO)?
- The 3Y average operating margin for COO stock is 16.25%.
- What is the 5Y average operating margin for The Cooper Companies, Inc. (COO)?
- The 5Y average operating margin for COO stock is 15.86%.
- What is the 10Y average operating margin for The Cooper Companies, Inc. (COO)?
- The 10Y average operating margin for COO stock is 16.49%.
- What is the 15Y average operating margin for The Cooper Companies, Inc. (COO)?
- The 15Y average operating margin for COO stock is 16.97%.
- What is the 20Y average operating margin for The Cooper Companies, Inc. (COO)?
- The 20Y average operating margin for COO stock is 15.82%.
The Cooper Companies, Inc. Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2025-10-31 | 16.69% |
| 2024-10-31 | 18.12% |
| 2023-10-31 | 14.84% |
| 2022-10-31 | 15.34% |
| 2021-10-31 | 17.31% |
| 2020-10-31 | 12.83% |
| 2019-10-31 | 20.60% |
| 2018-10-31 | 15.92% |
| 2017-10-31 | 20.06% |
| 2016-10-31 | 16.48% |
| 2015-10-31 | 13.17% |
| 2014-10-31 | 17.84% |
| 2013-10-31 | 19.27% |
| 2012-10-31 | 19.61% |
| 2011-10-31 | 17.10% |
| 2010-10-31 | 16.39% |
| 2009-10-31 | 13.87% |
| 2008-10-31 | 11.94% |
| 2007-10-31 | 4.82% |
| 2006-10-31 | 13.14% |
| 2005-10-31 | 16.84% |
| 2004-10-31 | 23.82% |
| 2003-10-31 | 23.13% |
| 2002-10-31 | 21.24% |
| 2001-10-31 | 23.34% |
| 2000-10-31 | 23.75% |
| 1999-10-31 | 23.48% |
| 1998-10-31 | 20.24% |
| 1997-10-31 | 14.06% |
| 1996-10-31 | 13.11% |
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White